Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zong Yang Yee"'
Publikováno v:
Heliyon, Vol 5, Iss 9, Pp e02468- (2019)
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. Nevertheless, breast adenocarcinoma cells can develop TRAIL resistan
Externí odkaz:
https://doaj.org/article/2f7f255bd1c0430282b647103b427b54
Autor:
Ling-Wei Hii, Felicia Fei-Lei Chung, Chun Wai Mai, Zong Yang Yee, Hong Hao Chan, Vijay Joseph Raja, Noah Elias Dephoure, Nigel J. Pyne, Susan Pyne, Chee-Onn Leong
Publikováno v:
Cells, Vol 9, Iss 4, p 886 (2020)
Cancer stem cells (CSCs) represent rare tumor cell populations capable of self-renewal, differentiation, and tumor initiation and are highly resistant to chemotherapy and radiotherapy. Thus, therapeutic approaches that can effectively target CSCs and
Externí odkaz:
https://doaj.org/article/9ced413142d1486c84837cbe544b8c98
Autor:
Susan Pyne, Ling-Wei Hii, Felicia Fei-Lei Chung, Vijay J. Raja, Noah Dephoure, Chee-Onn Leong, Hong Hao Chan, Chun-Wai Mai, Zong Yang Yee, Nigel J. Pyne
Publikováno v:
Cells
Volume 9
Issue 4
Cells, Vol 9, Iss 886, p 886 (2020)
Volume 9
Issue 4
Cells, Vol 9, Iss 886, p 886 (2020)
Cancer stem cells (CSCs) represent rare tumor cell populations capable of self-renewal, differentiation, and tumor initiation and are highly resistant to chemotherapy and radiotherapy. Thus, therapeutic approaches that can effectively target CSCs and
Publikováno v:
Heliyon, Vol 5, Iss 9, Pp e02468-(2019)
Heliyon
Heliyon
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent due to its selective killing on cancer cells while sparing the normal cells. Nevertheless, breast adenocarcinoma cells can develop TRAIL resistan
Publikováno v:
Journal of global antimicrobial resistance. 10
Objectives Currently, only a few antibiotics are available to treat methicillin-resistant Staphylococcus aureus (MRSA). One alternative approach includes adjuvants to antibiotic therapy. Non-steroidal anti-inflammatory drugs (NSAIDs) are non-antibiot